Skip to content
Eagle Pharmaceuticals Inc icon

Eagle Pharmaceuticals Inc

EGRXStocksPharmaceuticals MajorUnited StatesOTC Markets Stock ExchangeUSD

Price

$0.20

Today

-78.9%

YTD

-42.3%

About

Eagle Pharmaceuticals Inc is a specialty pharmaceutical company that focuses on innovation and the advancement of new product development. Primarily operating in the US, Eagle Pharmaceuticals focuses on treatments related to oncology and the central nervous system. The company is involved in the pharmaceuticals sector, specifically in drug manufacturing and the development of injectable products. Its mission is to provide better treatments and improved patient outcomes in areas that are underserved by current therapies. Keep up to date on the latest share price changes by adding EGRX stock to your eToro watchlist.

Price chart
Closing price history for EGRX (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)4.10
P/S (TTM)0.19
P/B (TTM)0.19
Market cap$8.70M
Cap tierMicro-cap
Industry avg P/E-43.29

Profitability

Gross margin69.74%
EBIT margin16.49%
Net margin7.99%
ROE4.88%
ROA3.04%

Earnings & Revenue

Revenue (TTM)$257.55M
Revenue growth (1Y)-5.4%
EPS (TTM)$0.91
Free cash flow$-9.39M
Total debt$72.45M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)-43.34
Employees135
Next earnings15 Mar '24
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

Eagle Pharmaceuticals Inc (EGRX) | Dirk Kuyken